CliffBio
small molecule

FLONASE SENSIMIST ALLERGY RELIEF

FLUTICASONE FUROATE

Loss of exclusivityOctober 2028latest FDA-listed patent expiry
CompanyHaleon →See this company's full patent-cliff portfolio

Drug detail

Brand nameFLONASE SENSIMIST ALLERGY RELIEF
Active ingredientFLUTICASONE FUROATE
Strength0.0275MG/SPRAY
Dosage formSPRAY, METERED
RouteNASAL
ModalitySmall molecule
FDA approvalAugust 2016
Marketing statusOTC

Listed patents

PatentExpiresType
8147461October 2028product
8347879July 2028product
8062264April 2026product

More from Haleon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

FLONASE SENSIMIST ALLERGY RELIEF patent cliff — loss of exclusivity October 2028 | CliffBio